NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Neumora Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.47−0.00 (-0.80%)
Close on Oct 19, 2026
- Market cap
- $87.03M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
40.4%
76M of 188M shares
Institutional holders
113
28 new, 28 sold out
Net institutional buying
6M
In Q2 2026
Insider trades, 12 months
3 buys · 16 sales
Net bought $13.91M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| K2 HealthVentures Equity Trust LLC | 8,997,035 | 5.01% | 13G (passive) amendment | Dec 31, 2025 |
| FMR LLC | 8,622,468 | 5.40% | 13G (passive) | Jun 28, 2024 |
| Paul L Berns | 8,226,272 | 5.10% | 13G (passive) amendment | Dec 31, 2024 |
| Kristina Burow | 33,965,419 | 18.70% | 13D (active) amendment | Mar 30, 2026 |
| Anup Arora | 11,397,310 | 6.60% | 13G (passive) | May 9, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NMRA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Siren, L.L.C. | 8,497,822 | 4.52% | $14.45M | – | 0.29% |
| BlackRock, Inc. | 7,791,869 | 4.15% | $13.25M | +5,737,553 | 0.00% |
| Softbank Group Corp. | 6,090,301 | 3.24% | $10.35M | – | 0.06% |
| Vanguard Capital Management LLC | 4,669,585 | 2.49% | $7.94M | +777,692 | 0.00% |
| MIC Capital Management UK LLP | 4,460,700 | 2.37% | $7.58M | – | 1.92% |
| FMR LLC | 3,498,869 | 1.86% | $5.95M | +211 | 0.00% |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3,309,123 | 1.76% | $5.63M | – | 0.06% |
| Geode Capital Management, LLC | 2,607,289 | 1.39% | $4.43M | +1,520,424 | 0.00% |
| ICONIQ Capital, LLC | 2,559,090 | 1.36% | $4.35M | – | 0.13% |
| Two Sigma Investments, LP | 2,244,829 | 1.19% | $3.82M | +208,137 | 0.00% |
| Orbimed Advisors LLC | 2,139,882 | 1.14% | $3.64M | New | 0.07% |
| Lunate Capital Ltd | 2,124,143 | 1.13% | $3.61M | – | 1.84% |
| Boxer Capital Management, LLC | 2,000,000 | 1.06% | $3.40M | New | 0.26% |
| Johnson & Johnson | 1,849,445 | 0.98% | $3.14M | – | 0.39% |
| State Street Corp | 1,582,119 | 0.84% | $2.69M | +1,183,400 | 0.00% |
| Tudor Investment Corp Et Al | 1,356,147 | 0.72% | $2.31M | +584,729 | 0.00% |
| Ikarian Capital, LLC | 1,278,408 | 0.68% | $2.17M | – | 0.23% |
| Renaissance Technologies LLC | 1,262,304 | 0.67% | $2.15M | −126,694 | 0.00% |
| Affinity Asset Advisors, LLC | 1,070,651 | 0.57% | $1.82M | New | 0.08% |
| Marshall Wace, Llp | 904,458 | 0.48% | $1.54M | −290,852 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 113 | 76M | 40.4% | 28 / 37 | 23 / 28 | 21M | 15M |
| Q1 2026 | 114 | 70M | 37.5% | 24 / 34 | 32 / 10 | 20M | 8M |
| Q4 2025 | 102 | 63M | 33.6% | 24 / 34 | 21 / 12 | 16M | 3M |
| Q3 2025 | 93 | 51M | 27.0% | 13 / 15 | 41 / 18 | 3M | 8M |
| Q2 2025 | 98 | 56M | 29.8% | 24 / 28 | 28 / 40 | 6M | 15M |
| Q1 2025 | 115 | 65M | 34.7% | 33 / 32 | 29 / 50 | 14M | 26M |
| Q4 2024 | 134 | 80M | 42.8% | 44 / 39 | 31 / 14 | 19M | 7M |
| Q3 2024 | 104 | 69M | 36.6% | 23 / 34 | 23 / 11 | 16M | 15M |
| Q2 2024 | 93 | 73M | 38.6% | 24 / 43 | 13 / 19 | 24M | 4M |
| Q1 2024 | 88 | 53M | 28.2% | 37 / 17 | 18 / 9 | 13M | 3M |
| Q4 2023 | 60 | 44M | 23.3% | 34 / 9 | 9 / 12 | 9M | 10M |
| Q3 2023 | 38 | 44M | 23.4% | 38 / 0 | 0 / 0 | 44M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of NMRA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3,435,554 | 1.83% | $5.84M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 2,504,450 | 1.33% | $4.26M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,126,060 | 0.60% | $1.91M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,116,548 | 0.59% | $1.80M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 872,018 | 0.46% | $1.48M | 0.01% | Jun 30, 2026 |
| iShares Biotechnology ETF | 543,567 | 0.29% | $924.06K | 0.01% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 465,376 | 0.25% | $860.95K | 0.00% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 415,640 | 0.22% | $768.93K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 344,428 | 0.18% | $585.53K | 0.04% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 250,075 | 0.13% | $402.62K | 0.01% | Jul 31, 2026 |
| Ultra-Small Company Market Fund | 225,000 | 0.12% | $382.50K | 0.26% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 221,105 | 0.12% | $355.98K | 0.00% | Jul 31, 2026 |
| Master Small Cap Index Series | 191,821 | 0.10% | $326.10K | 0.01% | Jun 30, 2026 |
| Vanguard Health Care Index Fund | 179,998 | 0.10% | $333.00K | 0.00% | May 31, 2026 |
| Invesco RAFI US 1500 Small-Mid ETF | 177,346 | 0.09% | $285.53K | 0.01% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Paul L. Berns | See Remarks, Director | 7,528,282 | 4.01% | Aug 21, 2026 |
| Joshua Pinto | President & CEO, Director | 209,950 | 0.11% | Aug 21, 2026 |
| Jason Duncan | See Remarks | – | – | Aug 21, 2026 |
| Daljit Singh Aurora | See Remarks | 91,490 | 0.05% | Aug 21, 2026 |
| Michael Lee Milligan | See Remarks | 21,034 | 0.01% | Aug 21, 2026 |
| Robert A. Lenz | Head of R&D | 309,092 | 0.16% | Feb 20, 2025 |
| Alaa Halawa | Director | 20,100 | 0.01% | May 29, 2026 |
| Matthew K. Fust | Director | 20,100 | 0.01% | May 29, 2026 |
| Kristina Burow | Director, 10% owner | 33,895,555 | 18.04% | May 29, 2026 |
| David Piacquad | Director | 20,100 | 0.01% | May 29, 2026 |
| Maykin Ho | Director | 20,100 | 0.01% | May 29, 2026 |
| Keith Crandell | 10% owner | – | – | Oct 29, 2025 |
| Robert Nelsen | 10% owner | 3,859,898 | 2.05% | Oct 29, 2025 |
| ARCH Venture Partners XII, L.P. | 10% owner | – | – | Oct 29, 2025 |
| Clinton Bybee | 10% owner | – | – | Oct 29, 2025 |
| ARCH Venture Partners VII, L.P. | 10% owner | – | – | Oct 29, 2025 |
| ARCH Venture Partners VII, LLC | 10% owner | 10,620,716 | 5.65% | Oct 29, 2025 |
| ARCH Venture Fund VII, L.P. | 10% owner | – | – | Oct 29, 2025 |
| ARCH Venture Partners XII, LLC | 10% owner | 33,847,838 | 18.01% | Oct 29, 2025 |
| ARCH Venture Fund X Overage, L.P. | 10% owner | – | – | Oct 29, 2025 |
| ARCH Venture Partners VIII, LLC | 10% owner | 33,847,838 | 18.01% | Oct 29, 2025 |
| ARCH Venture Fund VIII Overage, L.P. | 10% owner | – | – | Oct 29, 2025 |
| ARCH Venture Partners X, L.P. | 10% owner | 31,932,138 | 16.99% | Oct 29, 2025 |
| ARCH Venture Fund X, L.P. | 10% owner | – | – | Oct 29, 2025 |
| ARCH Venture Fund XII, L.P. | 10% owner | 4,131,207 | 2.20% | Oct 29, 2025 |
| ARCH Venture Partners X Overage, L.P. | 10% owner | – | – | Oct 29, 2025 |
| ARCH Venture Partners X, LLC | 10% owner | – | – | Oct 29, 2025 |
| Steven Gillis | 10% owner | – | – | Oct 29, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Daljit Singh Aurora See Remarks | Aug 21, 2026 | Option exercise | +21,055 | $0.72 | $15.16K | 21,055 |
| Daljit Singh Aurora See Remarks | Aug 21, 2026 | Sale | −21,055 | $1.60 | $33.69K | 0 |
| Daljit Singh Aurora See Remarks | Aug 21, 2026 | Sale | −20,553 | $1.59 | $32.68K | 48,750 |
| Daljit Singh Aurora See Remarks | Aug 21, 2026 | Option exercise | +20,553 | $0.72 | $14.80K | 69,303 |
| Daljit Singh Aurora See Remarks | Aug 20, 2026 | Sale | −67,741 | $1.51 | $102.29K | 48,750 |
| Daljit Singh Aurora See Remarks | Aug 20, 2026 | Option exercise | +21,685 | $0.72 | $15.61K | 21,685 |
| Daljit Singh Aurora See Remarks | Aug 20, 2026 | Option exercise | +45,026 | $0.72 | $32.42K | 66,711 |
| Daljit Singh Aurora See Remarks | Aug 20, 2026 | Sale | −66,711 | $1.51 | $100.73K | 0 |
| Daljit Singh Aurora See Remarks | Aug 20, 2026 | Option exercise | +67,741 | $0.72 | $48.77K | 116,491 |
| Daljit Singh Aurora See Remarks | Aug 19, 2026 | Option exercise | +13,268 | $0.72 | $9.55K | 62,018 |
| Daljit Singh Aurora See Remarks | Aug 19, 2026 | Option exercise | +17,732 | $0.72 | $12.77K | 79,750 |
| Daljit Singh Aurora See Remarks | Aug 19, 2026 | Sale | −31,000 | $1.65 | $51.15K | 48,750 |
| Daljit Singh Aurora See Remarks | Aug 19, 2026 | Option exercise | +30,918 | $0.72 | $22.26K | 30,918 |
| Daljit Singh Aurora See Remarks | Aug 19, 2026 | Sale | −30,918 | $1.65 | $51.01K | 0 |
| Daljit Singh Aurora See Remarks | Aug 18, 2026 | Option exercise | +34,162 | $0.72 | $24.60K | 82,912 |
| Daljit Singh Aurora See Remarks | Aug 18, 2026 | Sale | −34,162 | $1.58 | $53.98K | 48,750 |
| Daljit Singh Aurora See Remarks | Aug 18, 2026 | Option exercise | +34,987 | $0.72 | $25.19K | 34,987 |
| Daljit Singh Aurora See Remarks | Aug 18, 2026 | Sale | −34,987 | $1.59 | $55.63K | 0 |
| Daljit Singh Aurora See Remarks | Aug 17, 2026 | Option exercise | +1 | $0.72 | $1 | 140,440 |
| Daljit Singh Aurora See Remarks | Aug 17, 2026 | Sale | −34,020 | $1.49 | $50.69K | 48,750 |
| Daljit Singh Aurora See Remarks | Aug 17, 2026 | Sale | −57,670 | $1.51 | $87.08K | 82,770 |
| Daljit Singh Aurora See Remarks | Aug 17, 2026 | Option exercise | +1,424 | $0.72 | $1.03K | 140,439 |
| Daljit Singh Aurora See Remarks | Aug 17, 2026 | Option exercise | +25,279 | $0.72 | $18.20K | 25,279 |
| Daljit Singh Aurora See Remarks | Aug 17, 2026 | Option exercise | +29,737 | $0.72 | $21.41K | 55,016 |
| Daljit Singh Aurora See Remarks | Aug 17, 2026 | Sale | −55,016 | $1.50 | $82.52K | 0 |
| Daljit Singh Aurora See Remarks | Aug 17, 2026 | Option exercise | +15,355 | $0.72 | $11.06K | 139,015 |
| Daljit Singh Aurora See Remarks | Aug 17, 2026 | Option exercise | +40,890 | $0.72 | $29.44K | 123,660 |
| Paul L. Berns See Remarks, Director | Feb 17, 2026 | Sale | −9,819 | $3.51 | $34.46K | 7,395,185 |
| Daljit Singh Aurora See Remarks | Feb 17, 2026 | Sale | −6,165 | $3.56 | $21.95K | 82,770 |
| Joshua Pinto President | Feb 17, 2026 | Sale | −5,967 | $3.54 | $21.12K | 57,783 |
| Michael Lee Milligan See Remarks | Feb 17, 2026 | Sale(10b5-1 plan) | −1,436 | $3.57 | $5.13K | 21,034 |
| Daljit Singh Aurora See Remarks | Nov 11, 2025 | Sale(10b5-1 plan) | −114,703 | $2.68 | $307.40K | 0 |
| Kristina Burow Director, 10% owner | Oct 27, 2025 | Buy | +1,915,700 | $2.61 | $5.00M | 6,046,907 |
| ARCH Venture Partners XII, LLC 10% owner | Oct 27, 2025 | Buy | +1,915,700 | $2.61 | $5.00M | 6,046,907 |
| ARCH Venture Partners VIII, LLC 10% owner | Oct 27, 2025 | Buy | +1,915,700 | $2.61 | $5.00M | 6,046,907 |
| Joshua Pinto President | May 21, 2025 | Gift | +13,202 | – | – | 152,167 |
| Joshua Pinto President | May 21, 2025 | Gift | −13,202 | – | – | 63,750 |
| Michael Lee Milligan See Remarks | Feb 18, 2025 | Sale(10b5-1 plan) | −1,978 | $1.69 | $3.34K | 22,470 |
| Daljit Singh Aurora Chief Strategy Officer | Feb 18, 2025 | Sale(10b5-1 plan) | −8,565 | $1.68 | $14.39K | 88,935 |
| Paul L. Berns See Remarks, Director | Feb 18, 2025 | Sale(10b5-1 plan) | −13,871 | $1.69 | $23.44K | 7,405,004 |
| Joshua Pinto President | Feb 18, 2025 | Sale(10b5-1 plan) | −8,048 | $1.67 | $13.44K | 76,952 |
| Robert A. Lenz Head of R&D | Feb 18, 2025 | Sale(10b5-1 plan) | −5,614 | $1.67 | $9.38K | 309,092 |
| Paul L. Berns Director | Dec 27, 2024 | Gift | −133,097 | – | – | 7,551,972 |
| Paul L. Berns Director | Dec 27, 2024 | Gift | −133,097 | – | – | 7,418,875 |
| Paul L. Berns Director | Dec 27, 2024 | Gift | −133,097 | – | – | 7,685,069 |
| Matthew K. Fust Director | Oct 18, 2024 | Sale(10b5-1 plan) | −14,049 | $17.03 | $239.25K | 20,100 |
| Matthew K. Fust Director | Oct 18, 2024 | Option exercise | +7,844 | $2.52 | $19.77K | 34,149 |
| Matthew K. Fust Director | Oct 18, 2024 | Option exercise | +6,205 | $8.79 | $54.54K | 26,305 |
| Matthew K. Fust Director | Oct 17, 2024 | Sale(10b5-1 plan) | −7,739 | $17.01 | $131.64K | 20,100 |
| Matthew K. Fust Director | Oct 17, 2024 | Option exercise | +2,156 | $2.52 | $5.43K | 27,839 |
| Matthew K. Fust Director | Oct 17, 2024 | Option exercise | +1,800 | $8.79 | $15.82K | 25,683 |
| Matthew K. Fust Director | Oct 17, 2024 | Option exercise | +3,783 | $8.32 | $31.47K | 23,883 |
| Robert A. Lenz Head of R&D | Oct 10, 2024 | Sale(10b5-1 plan) | −8,260 | $15.09 | $124.64K | 314,706 |
| Robert A. Lenz Head of R&D | Oct 9, 2024 | Sale(10b5-1 plan) | −5,563 | $15.01 | $83.50K | 322,966 |
| Robert A. Lenz Head of R&D | Sep 18, 2024 | Sale(10b5-1 plan) | −10,676 | $12.09 | $129.07K | 328,529 |
| Robert A. Lenz Head of R&D | Sep 17, 2024 | Sale(10b5-1 plan) | −30,788 | $11.81 | $363.61K | 339,205 |
| Robert A. Lenz Head of R&D | Sep 12, 2024 | Sale(10b5-1 plan) | −32,948 | $11.43 | $376.60K | 369,993 |
| Joshua Pinto Chief Financial Officer | Aug 27, 2024 | Sale(10b5-1 plan) | −15,693 | $11.39 | $178.74K | 138,965 |
| Joshua Pinto Chief Financial Officer | Aug 26, 2024 | Sale(10b5-1 plan) | −31,642 | $11.78 | $372.74K | 154,658 |
| Joshua Pinto Chief Financial Officer | Aug 23, 2024 | Sale(10b5-1 plan) | −24,169 | $11.59 | $280.12K | 186,300 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Daljit Singh Aurora Officer | Aug 21, 2026 | 41,608 | $66.38K | Aug 21, 2026 | Exercise of employee stock options |
| Daljit Singh Aurora Officer | Aug 20, 2026 | 134,452 | $203.58K | Aug 20, 2026 | Exercise of employee stock options |
| Daljit Singh Aurora Officer | Aug 19, 2026 | 61,918 | $101.92K | Aug 19, 2026 | Exercise of employee stock options |
| Daljit Singh Aurora Officer | Aug 18, 2026 | 69,149 | $109.62K | Aug 18, 2026 | Exercise of employee stock options |
| Daljit Singh Aurora Officer | Aug 17, 2026 | 146,706 | $220.14K | Aug 17, 2026 | Exercise of employee stock options |
| Michael Lee Milligan Officer | Feb 17, 2026 | 1,436 | $5.12K | Feb 17, 2026 | Vesting of restricted stock unit award |
| Joshua Pinto Officer | Feb 17, 2026 | 5,967 | $21.09K | Feb 17, 2026 | Vesting of restricted stock unit award |
| Daljit Singh Aurora Officer | Feb 17, 2026 | 6,165 | $21.92K | Feb 17, 2026 | Vesting of restricted stock unit award |
| Paul L. Berns Officer | Feb 17, 2026 | 9,819 | $34.46K | Feb 17, 2026 | Vesting of restricted stock unit award |
| Family Trust Aurora Director, Officer | Nov 12, 2025 | 114,703 | $307.03K | Nov 11, 2025 | Stock Bonus |
| Gosebruch Henry Officer, Director | Mar 12, 2025 | 15,000 | $21.45K | Mar 12, 2025 | Open Market Purchase |
| Paul L. Berns Officer | Feb 18, 2025 | 13,871 | $23.47K | Feb 18, 2025 | Vesting of restricted stock unit award |
| Henry O. Gosebruch Officer, Director | Feb 18, 2025 | 6,857 | $11.46K | Feb 18, 2025 | Vesting of restricted stock unit award |
| Michael Lee Milligan Officer | Feb 18, 2025 | 1,978 | $3.35K | Feb 18, 2025 | Vesting of restricted stock unit award |
| Joshua Pinto Officer | Feb 18, 2025 | 8,048 | $13.48K | Feb 18, 2025 | Vesting of restricted stock unit award |